Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kukreja, P.
Right arrow Articles by Agrawal, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kukreja, P.
Right arrow Articles by Agrawal, K. C.
[Cancer Research 65, 9891-9898, November 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1{alpha} (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-{kappa}B Activation

Promil Kukreja1, Asim B. Abdel-Mageed2, Debasis Mondal1, Kai Liu2 and Krishna C. Agrawal1

Departments of 1 Pharmacology and 2 Urology, Tulane University Health Sciences Center, New Orleans, Louisiana

Requests for reprints: Krishna C. Agrawal, Department of Pharmacology, SL-83, Tulane University Health Sciences Center, New Orleans, LA 70112. Phone: 504-988-5444; Fax: 504-988-5283; E-mail: agrawal{at}tulane.edu.

The chemokine stromal-derived factor-1{alpha} (SDF-1{alpha}/CXCL-12) and its receptor, CXCR4, play a crucial role in adhesion and transendothelium migration (TEM) of prostate cancer cells. We tested the hypothesis that enhanced expression of CXCR4 in prostate cancer cells is dependent upon SDF-1{alpha}-mediated activation of nuclear factor-{kappa}B (NF-{kappa}B). SDF-1{alpha} increased the CXCR4 mRNA and protein expression in PC-3 cells but not in LNCaP cells. Similarly, SDF-1{alpha} enhanced the NF-{kappa}B-dependent transcriptional activity in PC-3 cells but not in LNCaP cells. SDF-1{alpha} increased PC-3 cell adhesion to the human umbilical vein endothelial cell monolayer and enhanced TEM, which was abrogated with anti-CXCR4 monoclonal antibody (mAb). Suppression of NF-{kappa}B activity in PC-3 cells by a mutant I{kappa}B{alpha} super-repressor adenoviral vector decreased the CXCR4 mRNA expression and inhibited adhesion and TEM. Transient overexpression of p65 subunit of NF-{kappa}B in PC-3 cells up-regulated CXCR4 receptor expression and increased the adhesion and TEM of these cells in response to SDF-1{alpha} gradient. Treatment of PC-3 cells with SDF-1{alpha} leads to nuclear translocation of NF-{kappa}B protein within 15 to 30 minutes, which correlated with I{kappa}B{alpha} phosphorylation. A p42/44 mitogen-activated protein kinase [MAPK, extracellular signal regulated kinase-1/2 (ERK-1/2)] biphasic activation pattern was observed in these cells at 15 minutes and 3 hours after SDF-1{alpha} treatment. Phosphorylation of I{kappa}B kinase {alpha} was observed within 30 minutes, which was blocked by PD98059 [MAPK kinase (MEK) inhibitor]. PD98059 cotreatment significantly inhibited SDF-1{alpha}-induced NF-{kappa}B reporter activity and CXCR4 receptor expression as shown by flow cytometry. These data suggest that SDF-1{alpha}-induced expression of CXCR4 in PC-3 cells is dependent on MEK/ERK signaling cascade and NF-{kappa}B activation.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
E. J. Villablanca, D. Zhou, B. Valentinis, A. Negro, L. Raccosta, L. Mauri, A. Prinetti, S. Sonnino, C. Bordignon, C. Traversari, et al.
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo
J. Leukoc. Biol., September 1, 2008; 84(3): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. O. Rehman and C.-Y. Wang
SDF-1{alpha} Promotes Invasion of Head and Neck Squamous Cell Carcinoma by Activating NF-{kappa}B
J. Biol. Chem., July 18, 2008; 283(29): 19888 - 19894.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Najy, K. C. Day, and M. L. Day
ADAM15 Supports Prostate Cancer Metastasis by Modulating Tumor Cell-Endothelial Cell Interaction
Cancer Res., February 15, 2008; 68(4): 1092 - 1099.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Tazaki, K. Miyazaki, E. Hiyama, T. Nakamoto, R. Sakai, N. Yamasaki, Z.-i. Honda, M. Noda, N. Miyasaka, T. Sueda, et al.
Functional analysis of Src homology 3-encoding exon (exon 2) of p130Cas in primary fibroblasts derived from exon 2-specific knockout mice.
Genes Cells, February 1, 2008; 13(2): 145 - 157.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-H. Tang, T.-W. Tan, W.-M. Fu, and R.-S. Yang
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis
Carcinogenesis, January 1, 2008; 29(1): 35 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Begley, J. W. MacDonald, M. L. Day, and J. A. Macoska
CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells
J. Biol. Chem., September 14, 2007; 282(37): 26767 - 26774.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C987 - C995.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. W. Rahman, F. H. Sarkar, S. Banerjee, Z. Wang, D. J. Liao, X. Hong, and N. H. Sarkar
Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
Mol. Cancer Ther., November 1, 2006; 5(11): 2747 - 2756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.